On May 30, 2022, Fred Driscoll, the Corporate Secretary of Renovacor, Inc. (the “Company”), notified the Company of his decision to resign effective as of June 17, 2022 (the “Effective Date”). Mr. Driscoll resigned for personal reasons and not as a result of any disagreement with the Company or its independent registered public accountants on any matter relating to the Company's financial or accounting operations, policies or practices. On June 2, 2022, the Board appointed Joseph Carroll, the Company's current Vice President, Finance, as Chief Accounting Officer and Corporate Secretary, effective as of the Effective Date.

Mr. Carroll will assume the duties of the principal accounting officer of the Company as of the Effective Date. Mr. Carroll has served as the Company's Vice President, Finance since June 2021. Prior to joining the Company, he served in a variety of roles at Idera Pharmaceuticals, including as Associate Director, Finance, and Manager of Financial Compliance and Reporting, from June 2017 to June 2021.

He previously served in a financial reporting role at Fibrocell Science, from August 2015 to June 2017 where he assisted the company with its public financial reporting obligations. Prior to this time, Mr. Carroll served as Manager at RSM US LLP (formerly known as McGladrey LLP) from January 2008 to August 2015 where he provided assurance-related services and managed financial and operational engagements. Mr. Carroll obtained his B.S. in accounting and business management from West Chester University of Pennsylvania and is a licensed CPA.